My exotic discovery
GLP-1 is released in your gut after eating
In the past decades, several groups have found that drugs that harmine and other dual specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors are able to induce proliferation of human -cell and increase islet mass in vitro and vivo, and its pro-proliferative effects primarily operate via translocation of nuclear factor of activated T-cells (NFAT) transcription factors to the nucleus, with the consequent transactivation of cyclins such as cyclin A, CDKs such as CDK1, and repression of CDK-inhibitors such as p15 INK4 , p21 CIP1 , and p57 KIP2 [42, 43]
The interplay of iron, oxidative stress, and -synuclein in parkinsons disease progression
Semaglutide, a GLP-1 receptor agonist marketed as Ozempic for type 2 diabetes and Wegovy for chronic weight management, does not damage or permanently impair metabolic function
Patients can also expedite the weight loss process by combining the semaglutide with diet and excercise
